They will present the Antimicrobial Resistance Benchmark, which is the first independent assessment of pharma company action on antimicrobial resistance, covering antimicrobial R&D, responsible manufacturing and production and appropriate access and stewardship. The objective is to inform the participants about the activities of pharmaceutical companies to limit AMR, highlight leading practices and opportunities, and trigger a conversation on how purchasers can move forward with sustainable procurement of pharmaceuticals.

The event aims to address the environmental and social issues that the health sector is responsible for. A range of topics on environmental and social sustainability in the production of health commodities and delivery of healthcare services will be covered. Read more >>



Related posts